Value proposition

A great opportunity to share information on the most recent developments in oncology, immunology and liquid biopsy.

The Hamburg ISMRC meeting is a great opportunity to gather for three days and share information on the most recent technical developments, clinical trials and latest breaking news with leading researchers in the oncology, immunology and liquid biopsy fields.

The 2023 meeting in Hamburg is supported by the European Liquid Biopsy Society (ELBS), a large consortium of institutions from academia and industry with the vision of bringing liquid biopsy assays into clinical practice.

The Hamburg-ISMRC 2023 programme will be focusing on Minimal Residual Cancer as Target of Cancer Immunotherapy and Liquid Biopsy Diagnostics as well as LIQUID BIOPSY in a broader sense. The congress will include presentations on Circulating Tumor Cells (CTCs), circulating nucleic acids (DNA, miRNA) and exosomes, with emphasis on clinical studies as well as the biology of metastasis and a strong focus on immune biology and immunotherapy.